Parnell Pharmaceuticals Holdings Ltd. (PARNF)
Stock Price: $0.3725 USD
-0.0130 (-3.25%)
Updated Jan 14, 2021 11:41 AM EST - Market closed
| Market Cap | 2.85M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 20.00M |
| EPS (ttm) | -1.05 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 14 |
| Last Price | $0.3725 |
| Previous Close | $0.3850 |
| Change ($) | -0.0130 |
| Change (%) | -3.25% |
| Day's Open | 0.3725 |
| Day's Range | 0.3725 - 0.3725 |
| Day's Volume | 370 |
| 52-Week Range | 0.04 - 0.395 |
News
There are no news available yet.
About PARNF
Parnell Pharmaceuticals Holdings Ltd, a veterinary pharmaceutical company, focuses on developing, manufacturing, and commercializing various animal health solutions. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for improving cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical p... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | IPO Date Jun 18, 2014 |
| CEO Robert Joseph | |
| Stock Exchange OTCMKTS | Ticker Symbol PARNF |